0

The full content of Annals is available to subscribers

Subscribe/Learn More  >
Reviews |

Interactions of Warfarin with Drugs and Food

Philip S. Wells, MD, MSc, FRCP(C); Anne M. Holbrook, MD, PharmD, MSc, FRCP(C); N. Renee Crowther, BSc; and Jack Hirsh, MD, FRCP(C)
[+] Article and Author Information

From McMaster University; Centre for Evaluation of Medicines, St. Joseph's Hospital; the Hamilton Civic Hospitals Research Centre, Hamilton, Ontario, Canada. Grant Support: In part by Hamilton Civic Hospitals Research Centre and The Centre for Evaluation of Medicines, St. Joseph's Hospital, Ontario, Canada. Dr. Wells is the recipient of a McLaughlin scholarship from the University of Ottawa. Dr. Hirsh is a Distinguished Research Professor of the Heart and Stroke Foundation of Canada and is a Trillium Award recipient from the Ministry of Health.


Copyright ©2004 by the American College of Physicians


Ann Intern Med. 1994;121(9):676-683. doi:10.7326/0003-4819-121-9-199411010-00009
Text Size: A A A

Purpose: To evaluate the quality of studies about drugs and food interactions with warfarin and their clinical relevance.

Data Sources: MEDLINE and TOXLINE databases from 1966 to October 1993 using the Medical Subject Headings warfarin, drug interactions, and English only.

Study Selection: All articles reporting original data on drug and food interactions with warfarin.

Data Extraction: Each report, rated independently by at least two investigators (using causality assessment), received a summary score indicating the level of assurance (level 1 = highly probable, level 2 = probable, level 3 = possible, and level 4 = doubtful) that a clinically important interaction had or had not occurred. Inter-rater agreement was assessed using a weighted κ statistic.

Results: Of 793 retrieved citations, 120 contained original reports on 186 interactions. The weighted κ statistic was 0.67, representing substantial agreement. Of 86 different drugs and foods appraised, 43 had level 1 evidence. Of these, 26 drugs and foods did interact with warfarin. Warfarin's anticoagulant effect was potentiated by 6 antibiotics (cotrimoxazole, erythromycin, fluconazole, isoniazid, metronidazole, and miconazole); 5 cardiac drugs (amiodarone, clofibrate, propafenone, propranolol, and sulfinpyrazone); phenylbutazone; piroxicam; alcohol (only with concomitant liver disease); cimetidine; and omeprazole. Three patients had a hemorrhage at the time of a potentiating interaction (caused by alcohol, isoniazid, and phenylbutazone). Warfarin's anticoagulant effect was inhibited by 3 antibiotics (griseofulvin, rifampin, and nafcillin); 3 drugs active on the central nervous system (barbiturates, carbamazepine, and chlordiazepoxide); cholestyramine; sucralfate; foods high in vitamin K; and large amounts of avocado.

Conclusions: Many drugs and foods interact with warfarin, including antibiotics, drugs affecting the central nervous system, and cardiac medications. Many of these drug interactions increase warfarin's anticoagulant effect.

Topics

warfarin ; food

Figures

Tables

References

Letters

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Comments

Submit a Comment
Submit a Comment

Summary for Patients

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.

Toolkit

Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Advertisement
Related Point of Care
Topic Collections
PubMed Articles
Oral anticoagulation in atrial fibrillation. Cardiovasc Hematol Agents Med Chem 2014;12(1):34-41.
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)